Physician
Subbiah, Vishakalakshmi
Subbiah, Vishakalakshmi was paid $899.84 by Medicaid between Jan 2018 and Feb 2023, across 44 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.
33Billing provider infoSUBBIAH, VISHAKALAKSHMI
VAN NUYS, CA 91405
VAN NUYS, CA 91405
33aNPI1790906568assigned 05/01/2007
33bProvider typeAdult Medicine Physician
28Total paid$899.84
24GClaims20,540
24DCodes billed44
24AFirst – last monthJan 2018 – Feb 2023
Compared with peers
Next to other Adult Medicine Physician providers in California
Rank by total paid#46 of 72
Median peer was paid$4K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,258 | $193.92 | |
| 2019 | 2,996 | $705.92 | |
| 2020 | 5,233 | $0.00 | |
| 2021 | 5,436 | $0.00 | |
| 2022 | 3,871 | $0.00 | |
| 2023 | 746 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 2,827 | 2,156 | $274.64 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 30% | 408 | 405 | $268.09 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 19% | 392 | 390 | $167.79 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 14% | 1,697 | 1,513 | $125.44 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.8% | 712 | 547 | $60.88 |
| 86592 | <1% | 155 | 155 | $3.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 366 | 336 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 557 | 554 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 258 | 255 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,392 | 1,367 | $0.00 |
| 99443 | 0% | 173 | 163 | $0.00 | |
| 85027 | 0% | 95 | 94 | $0.00 |
32 more codes
| 36415 | Collection of venous blood by venipuncture | 0% | 3,142 | $0.00 |
| 90686 | 0% | 194 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 81 | $0.00 |
| 87088 | 0% | 25 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 1,696 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 1,635 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 45 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 135 | $0.00 |
| 99441 | 0% | 227 | $0.00 | |
| 86780 | 0% | 87 | $0.00 | |
| 4450F | 0% | 66 | $0.00 | |
| 1220F | 0% | 74 | $0.00 | |
| 92551 | 0% | 51 | $0.00 | |
| 87340 | 0% | 13 | $0.00 | |
| 82043 | 0% | 30 | $0.00 | |
| 81001 | 0% | 40 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 12 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 38 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 27 | $0.00 |
| 99442 | 0% | 1,144 | $0.00 | |
| 86703 | 0% | 513 | $0.00 | |
| 80061 | Lipid panel | 0% | 1,611 | $0.00 |
| 99173 | 0% | 120 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 117 | $0.00 |
| 80076 | 0% | 66 | $0.00 | |
| 82540 | 0% | 30 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 115 | $0.00 |
| 84439 | 0% | 12 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 70 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 27 | $0.00 |
| 84481 | 0% | 12 | $0.00 | |
| 1033F | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.